this post was submitted on 28 Sep 2025
22 points (100.0% liked)

Futurology

3393 readers
4 users here now

founded 2 years ago
MODERATORS
 

Lenacapavir will still cost $28,000 a year in the US.

Patents should allow the first generic versions of Semaglutide (Ozempic) to appear next year. Again in low income countries, not developed nations.

Are we going to see a future trend of poorer countries bettering developed countries in health outcomes?

Philanthropies Strike a Promising Deal to Turn Back H.I.V.

all 5 comments
sorted by: hot top controversial new old
[–] null_dot@lemmy.dbzer0.com 4 points 1 month ago

In Australia this is going to be available under our Pharmaceutical Benefits Scheme soon. Essentially the federal government would / will be the only Australian buyer from the manufacturer.

The govt will pay the commercial price, but they have vastly better bargaining power. Then patients receive it for free.

Existing anti-retro-virals were also expensive when first released. $2,000 per patient / month wouldn't be extreme.

[–] belated_frog_pants@beehaw.org 3 points 1 month ago

$28000 because the US hates its citizens

[–] ExtremeDullard@piefed.social 2 points 1 month ago (2 children)

Give it a few months and America will join the $40 / patient / year low-income country club.

[–] rumschlumpel@feddit.org 4 points 1 month ago

Yeah, but they ain't getting the shot, because vax bad.